Document is current

Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?

Crossref DOI link: https://doi.org/10.17352/2455-8591.000002

Published Online: 2015-08-14

Update policy: https://doi.org/10.17352/crossmark-policy